The cost of bone marrow transplantation in Israel typically ranges from $255,000 to $306,000. Prices depend on the type of transplant (autologous or allogeneic), the hospital, the donor match process, and the complexity of the case. In the United States, the average price is $600,000 (per ASBMT). This means bone marrow transplantation in Israel can cost about 53% less than in the U.S.
Israeli hospitals usually include pre-transplant evaluation, stem cell collection, the transplant procedure, hospitalization, supportive medications, and follow-up care. In the U.S., costs for donor testing, cell harvesting, hospital stays, and post-transplant monitoring are often billed separately. Always confirm exactly what each clinic’s package covers.
Why choose Israel for bone marrow transplantation?
Access advanced Bone marrow transplantation solutions in trusted clinics .
| Israel | Turkey | Austria | |
| Bone marrow transplantation | from $255,000 | from $27,500 | from $140,000 |
| Haploidentical Stem Cell Transplantation | - | from $77,500 | from $180,000 |
| Autologous bone marrow transplantation | - | from $32,500 | from $50,000 |
| Allogenic bone marrow transplantation from an unrelated donor | - | from $66,000 | from $180,000 |
| Allogenic bone marrow transplantation from a related donor | - | from $57,500 | from $150,000 |
Medically reviewed by
Fahad MawloodWritten by Anna Leonova
When considering Bone marrow transplantation, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
This procedure involves collecting stem cells from a patient's own bone marrow, processing them, and reinfusing to aid in recovery, especially for cancer treatment, with minimal rejection risk.
This procedure involves transferring healthy stem cells from a closely matched family member to replace damaged bone marrow in patients with certain diseases.
This procedure involves transplanting stem cells from a donor who is not genetically related to the recipient, used primarily for treating blood-related diseases.
Involves using stem cells from a half-matched donor, typically a family member, to treat various blood disorders and cancers.